153 related articles for article (PubMed ID: 36453466)
1. Physicians' experience in blood supply shortages and the top factors that impact the clinical, economic, and humanistic outcomes of patients with myelodysplastic syndromes in 5 European countries.
Gupta S; Kulasekararaj AG; Costantino H; Grisolano J; Tang J; Jones S; Tang D
Curr Med Res Opin; 2023 Feb; 39(2):239-247. PubMed ID: 36453466
[TBL] [Abstract][Full Text] [Related]
2. Red blood cell transfusion in myelodysplastic syndromes: A systematic review.
Kaka S; Jahangirnia A; Beauregard N; Davis A; Tinmouth A; Chin-Yee N
Transfus Med; 2022 Feb; 32(1):3-23. PubMed ID: 34927286
[TBL] [Abstract][Full Text] [Related]
3. Association between transfusion status and clinical and economic outcomes in patients with myelodysplastic syndromes from the physicians' perspective.
Gupta S; Kulasekararaj AG; Costantino H; Grisolano J; Tang J; Jones S; Tang D
Cancer Rep (Hoboken); 2023 Jan; 6(1):e1680. PubMed ID: 35942648
[TBL] [Abstract][Full Text] [Related]
4. Patient and physician perceptions about blood transfusions in the myelodysplastic syndromes.
King D; Schmidt R; Lesser M; Houk A; Salkeld E; Cogle CR
Leuk Res; 2020 Sep; 96():106425. PubMed ID: 32702549
[TBL] [Abstract][Full Text] [Related]
5. The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry.
Buckstein R; Chodirker L; Yee KWL; Geddes M; Leitch HA; Christou G; Banerji V; Leber B; Khalaf D; St-Hilaire E; Finn N; Nevill T; Keating MM; Storring J; Parmentier A; Thambipillai A; Tang D; Westcott C; Cameron C; Spin P
Leuk Lymphoma; 2023 Mar; 64(3):651-661. PubMed ID: 36606533
[TBL] [Abstract][Full Text] [Related]
6. Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes.
Jabbour E; Kantarjian HM; Koller C; Taher A
Cancer; 2008 Mar; 112(5):1089-95. PubMed ID: 18186499
[TBL] [Abstract][Full Text] [Related]
7. Transfusion independence in patients with myelodysplastic syndromes: impact on outcomes and quality of life.
Balducci L
Cancer; 2006 May; 106(10):2087-94. PubMed ID: 16607649
[TBL] [Abstract][Full Text] [Related]
8. Transfusion Support of Patients with Myelodysplastic Syndromes.
Guarente J; Tormey C
Clin Lab Med; 2023 Dec; 43(4):669-683. PubMed ID: 37865510
[TBL] [Abstract][Full Text] [Related]
9. Association between red blood cell transfusion dependence and burden in patients with myelodysplastic syndromes: A systematic literature review and meta-analysis.
Braga Lemos M; Rodrigues SR; Schroeder T; Kulasekararaj AG; Matos JE; Tang D
Eur J Haematol; 2021 Jul; 107(1):3-23. PubMed ID: 33715214
[TBL] [Abstract][Full Text] [Related]
10. The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes.
Platzbecker U; Hofbauer LC; Ehninger G; Hölig K
Leuk Res; 2012 May; 36(5):525-36. PubMed ID: 22300879
[TBL] [Abstract][Full Text] [Related]
11. Red Blood Cell Transfusion Dependency and Hyperferritinemia Are Associated with Impaired Survival in Patients Diagnosed with Myelodysplastic Syndromes: Results from the First Polish MDS-PALG Registry.
Waszczuk-Gajda A; Mądry K; Machowicz R; Drozd-Sokołowska J; Stella-Hołowiecka B; Mital A; Obara A; Szmigielska-Kapłon A; Sikorska A; Subocz E; Jędrzejczak WW; Dwilewicz-Trojaczek J
Adv Clin Exp Med; 2016; 25(4):633-41. PubMed ID: 27629836
[TBL] [Abstract][Full Text] [Related]
12. Red blood cell transfusion burden in myelodysplastic syndromes (MDS) with ring Sideroblasts (RS): A retrospective multicenter study by the Groupe Francophone des Myélodysplasies (GFM).
Jouzier C; Cherait A; Cony-Makhoul P; Hamel JF; Veloso M; Thepot S; Cluzeau T; Stamatoullas A; Garnier A; Guerci-Bresler A; Dimicoli-Salazar S; Pica GM; Cheze S; Santana C; Chermat F; Fenaux P; Park S
Transfusion; 2022 May; 62(5):961-973. PubMed ID: 35452143
[TBL] [Abstract][Full Text] [Related]
13. Impact of transfusion on survival in patients with myelodysplastic syndromes: Current knowledge, new insights and transfusion clinical practice.
Kaphan E; Laurin D; Lafeuillade B; Drillat P; Park S
Blood Rev; 2020 May; 41():100649. PubMed ID: 31918886
[TBL] [Abstract][Full Text] [Related]
14. Peri-transfusion quality-of-life assessment for patients with myelodysplastic syndromes.
Abel GA; Klepin HD; Magnavita ES; Jaung T; Lu W; Shallis RM; Hantel A; Bahl NE; Dellinger-Johnson R; Winer ES; Zeidan AM
Transfusion; 2021 Oct; 61(10):2830-2836. PubMed ID: 34251040
[TBL] [Abstract][Full Text] [Related]
15. Multi-national survey of transfusion experiences and preferences of patients with myelodysplastic syndrome.
Vijenthira A; Starkman R; Lin Y; Stanworth SJ; Bowen D; Harrison L; Wintrich S; Callum J; Buckstein R
Transfusion; 2022 Jul; 62(7):1355-1364. PubMed ID: 35686926
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys.
Sekeres MA; Schoonen WM; Kantarjian H; List A; Fryzek J; Paquette R; Maciejewski JP
J Natl Cancer Inst; 2008 Nov; 100(21):1542-51. PubMed ID: 18957672
[TBL] [Abstract][Full Text] [Related]
17. Erythropoiesis-stimulating agents versus RBC transfusion in MDS: comparison of long-term outcomes.
Mundle SD
Future Oncol; 2007 Aug; 3(4):397-403. PubMed ID: 17661714
[TBL] [Abstract][Full Text] [Related]
18. Rethinking the transfusion pathway in myelodysplastic syndromes: Study protocol for a novel randomized feasibility n-of-1 trial of weekly-interval red cell transfusion in myelodysplastic syndromes.
Mo A; Wood E; Shortt J; Charlton A; Evers D; Hoeks M; Pritchard E; Daly J; Hodgson C; Opat S; Bowen D; Reynolds J; Thi Phung Thao L; Stanworth SJ; McQuilten Z
Transfusion; 2024 Feb; 64(2):236-247. PubMed ID: 38214417
[TBL] [Abstract][Full Text] [Related]
19. Patterns of transfusion burden in an unselected population of patients with myelodysplastic syndromes: A population-based study.
Rozema J; van Roon EN; Kibbelaar RE; Veeger NJGM; Slim CL; de Wit H; Hoogendoorn M;
Transfusion; 2021 Oct; 61(10):2877-2884. PubMed ID: 34480360
[TBL] [Abstract][Full Text] [Related]
20. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
Sanz C; Nomdedeu M; Belkaid M; Martinez I; Nomdedeu B; Pereira A
Transfusion; 2013 Apr; 53(4):710-5. PubMed ID: 22845746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
